Key result
Incarceration during IBD hospitalization is linked to ~298% higher odds of 1-year readmission.
Why the study?
Individuals who are incarcerated often have limited access to first-line treatment and comprehensive health care, but readmissions among hospitalized patients with IBD based on incarceration status had not been compared.
Does incarceration increase the risk of readmission in patients hospitalized with inflammatory bowel disease?
Cohort (n=90)
No
Does incarceration increase the risk of readmission in patients hospitalized with inflammatory bowel disease?
Incarceration at the time of hospitalization for inflammatory bowel disease is associated with significantly higher odds of all-cause readmission at 1 year.
Answers are grounded in this paper and cite their sources.
May flag incarceration as a readmission risk marker in IBD; leaves open whether targeted support reduces events.
Background and Aims Individuals who are incarcerated often have limited access to first-line treatment and comprehensive health care. In this study, we aimed to compare the frequency of readmissions among patients with inflammatory bowel disease (IBD) receiving care at a community hospital who were and were not incarcerated at the time of hospitalization. Methods We analyzed records from Lemuel Shattuck Hospital for all patients admitted between January 1, 2011, and December 31, 2019. Patients with IBD were identified using International Classification of Diseases codes. The primary outcome was all-cause readmission at 1 year following an IBD-related admission. Secondary outcomes were (1) all-cause readmission at 30 days, (2) IBD-related readmission at 30 days, and (3) IBD-related readmission at 1 year. Our indicator of interest was incarceration. Multivariable logistic regression models were built to describe predictors of all-cause readmissions at 1 year. Results Among the 6511 individuals hospitalized at Lemuel Shattuck Hospital between 2011 and 2019, 90 individuals (1.4%) had International Classification of Diseases codes for IBD, either ulcerative colitis (n = 44) and/or Crohn's disease (n = 39). Half (n = 46) of patients with IBD were incarcerated during hospital admission. Individuals who were incarcerated had a higher rate of all-cause readmissions at 1 year than those who were not incarcerated at the time of hospitalization (76.0% vs 41.5%, P = .005). Multivariable analysis showed patients who were incarcerated had 3.98 (95% confidence interval: 1.39–12.78) increased odds of all-cause readmission within 1 year. Conclusion Our results suggest individuals with IBD who are incarcerated may experience worse health outcomes than individuals who are not incarcerated, adding to a body of literature documenting the negative impact of incarceration on health.
No takes yet. Share an insight, caveat, or question.
Rich et al. (2023) conducted a cohort in Inflammatory bowel disease (n=90). Incarceration vs. Not incarcerated at the time of hospitalization was evaluated on All-cause readmission at 1 year following an IBD-related admission (OR 3.98, 95% CI 1.39-12.78, p=.005). Incarceration during hospitalization for inflammatory bowel disease was associated with increased odds of all-cause readmission at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: